The FMR1 gene produces a protein essential for normal brain development, and mutations in this gene cause fragile X syndrome, the most common inherited form of intellectual disability.
The FMR1 gene, located on the X chromosome, codes for the fragile X mental retardation 1 protein (FMRP). This protein regulates messenger RNA, ensuring proper synaptic connections in the brain. Without functional FMRP, neurons fail to communicate effectively, leading to cognitive impairments.
Most mutations involve expansions of CGG repeats in the FMR1 gene. Healthy individuals have 5-44 repeats, while those with fragile X syndrome often have over 200. These expansions silence the gene, preventing FMRP production.
| Repeat Range | Condition |
|---|---|
| 5-44 repeats | Normal |
| 45-54 repeats | Gray zone (intermediate risk) |
| 55-200 repeats | Premutation (risk of fragile X-associated disorders) |
| >200 repeats | Full mutation (fragile X syndrome) |
Fragile X syndrome causes intellectual disabilities, behavioral challenges, and distinctive facial features. Diagnosis involves genetic testing for FMR1 mutations. Early intervention improves outcomes, addressing speech delays and social difficulties.
Many confuse fragile X syndrome with autism, though they are distinct conditions. While both involve social and communication challenges, fragile X syndrome stems from FMR1 mutations, whereas autism has diverse genetic and environmental causes.
Scientists are exploring treatments targeting FMRP function. Drugs like metformin show promise in reducing CGG repeats. Clinical trials focus on improving cognitive and behavioral symptoms, offering hope for better management.
Understanding the FMR1 gene is important for diagnosing and treating fragile X syndrome. Research continues to uncover new insights into this complex genetic disorder.